1. US Food and Drug Administration. Regulatory Information. Best Pharmaceuticals for Children Act. http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/ucm148011.htm. Accessed March 27, 2013.
2. National Institutes of Health. Best Pharmaceuticals for Children Act. http://bpca.nichd.nih.gov/. Accessed March 27, 2013.
3. US Food and Drug Administration. Pediatric Research Equity Act. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM077853.pdf. Accessed March 27, 2013.
4. US Food and Drug Administration. Regulatory Information: Pediatric Provisions in the Food and Drug Safety and Innovation Act. http://www.fda.gov/RegulatoryInformation/Legislation/FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/FDASIA/ucm311038.htm. Accessed April 4, 2013.
5. Institute of Medicine of the National Academies. Addressing the barriers to pediatric drug development: Workshop summary. http://www.ncbi.nlm.nih.gov/books/NBK3994/pdf/TOC.pdf. Accessed March 27, 2013.